Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy. (4th May 2022) - Campochiaro, C; Tomelleri, A; Farina, N; Cavalli, G; De Luca, G; Palmisano, A; Peretto, G; Esposito, A; Rizzo, S; Basso, C; Matucci-Cerinic, M; Dagna, L